2. Search Result
Search Result
Results for "

PLP (139-151)

" in MedChemExpress (MCE) Product Catalog:

1

Inhibitors & Agonists

7

Peptides

Cat. No. Product Name Target Research Area
  • HY-P0129
    PLP (139-151)

    		Peptides Inflammation/Immunology
    PLP (139-151) is amino acid residue 139 to 151 of myelin proteolipid protein (PLP) used to induce experimental autoimmune encephalomyelitis (EAE).
  • HY-P1038A
    [SER140]-PLP(139-151) TFA

    		Peptides Others
    [SER140]-PLP(139-151) (TFA) is a fragment of myelin proteolipid protein .
  • HY-P10314
    [Leu144]-PLP (139-151)

    L144-PLP(139-151)

    		 Peptides Inflammation/Immunology
    [Leu144]-PLP (139-151) (L144-PLP(139-151)) is a peptide ligand of T cell receptor. [Leu144]-PLP (139-151) is a TCR antagonist for encephalitogenic Th1 clones, blocking their activation .
  • HY-P10315
    [Gln144]-PLP (139-151)

    Q144-PLP(139-151)

    		 Peptides Others
    [Gln144]-PLP (139-151) is an experimental antigen used to study T cells respond to both autoantigens and cross-reactive non-autoantigens. [Gln144]-PLP (139-151) activates T cells by binding to T-cell Receptor (TCR), which triggers an immune response. [Gln144]-PLP (139-151) can be used to study the regulation of autoimmune diseases .
  • HY-P10456
    [Leu144,Arg147]-PLP (139-151)

    		Peptides Inflammation/Immunology
    [Leu144,Arg147]-PLP (139-151) is a mutant peptide fragment of myelin proteolipid protein (PLP), with the tryptophan and histidine at positions 144 and 147 respectively replaced by leucine and arginine. [Leu144,Arg147]-PLP (139-151) also serves as a T cell receptor (TCR) antagonist for encephalitogenic Th1 clones, blocking their activation in vitro. Furthermore, [Leu144,Arg147]-PLP (139-151) can inhibit the development of experimental autoimmune encephalomyelitis (EAE) .
  • HY-P1038
    [SER140]-PLP(139-151)

    		Peptides Others
    [SER140]-PLP(139-151) is a fragment of myelin proteolipid protein.
  • HY-P3248
    J5 peptide

    Myelin basic protein (85-99) antagonist

    		 Biochemical Assay Reagents Inflammation/Immunology
    J5 peptide is an MBP inhibitor that competitively inhibits the binding of MBP85-99 to HLA-DR2. J5 peptide alleviates PLP139-151/MBP85-99-induced experimental autoimmune encephalomyelitis (EAE) in mice. J5 peptide can be used in research on inflammatory and immune diseases .

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: